Skip to main content
. 2015 Apr 9;32(4):319–340. doi: 10.1007/s12325-015-0200-x

Table 4.

Summary of adverse events

Placebo (N = 8) Luseogliflozin
0.5 mg (N = 8) 1 mg (N = 8) 2.5 mg (N = 8) 5 mg (N = 8)
Any adverse event, n 0 3 1 1 2
Any related event, n 0 1 0 0 0
 Constipation 0 1 0 0 0
 Diarrhea 0 1 0 0 0
 Dermatitis contact 0 0 1 0 0
 Pruritus 0 1 0 0 0
 Headache 0 1 0 0 1
 Blood urine present 0 0 0 0 1
 ALT increased 0 0 0 1 0
 γ-GTP increased 0 0 0 1 0

Values are presented as the number of subjects

ALT alanine aminotransferase, γ-GTP gamma-glutamyltransferase